Table of Contents
ISRN Neurology
Volume 2013, Article ID 592398, 8 pages
http://dx.doi.org/10.1155/2013/592398
Research Article

Flutamide Enhances Neuroprotective Effects of Testosterone during Experimental Cerebral Ischemia in Male Rats

1Department of Physiology, Medical School, Tehran University of Medical Sciences, Enghelab Street, Tehran 1411413137, Iran
2Department of Anatomy, Medical School, Tehran University of Medical Sciences, Enghelab Street, Tehran 1411413137, Iran

Received 11 November 2012; Accepted 18 December 2012

Academic Editors: A. Arboix, J. Chen, and H. Ovadia

Copyright © 2013 Hamed Fanaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. H. Park, J. H. Kim, S. J. Park et al., “Protective effect of hexane extracts of Uncaria sinensis against photothrombotic ischemic injury in mice,” Journal of Ethnopharmacology, vol. 138, no. 3, pp. 774–779, 2011. View at Publisher · View at Google Scholar
  2. M. Sakurazawa, K.-I. Katsura, M. Saito, S. Asoh, S. Ohta, and Y. Katayama, “Mild hypothermia enhanced the protective effect of protein therapy with transductive anti-death FNK protein using a rat focal transient cerebral ischemia model,” Brain Research, vol. 1430, pp. 86–92, 2012. View at Publisher · View at Google Scholar
  3. N. Suzuki, M. Suzuki, K. Murakami, K. Hamajo, T. Tsukamoto, and M. Shimojo, “Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates,” Brain Research, vol. 1430, pp. 93–100, 2012. View at Publisher · View at Google Scholar
  4. A. Dávalos, J. Alvarez-Sabín, J. Castillo et al., “Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial),” The Lancet, vol. 380, no. 9839, pp. 349–357, 2012. View at Publisher · View at Google Scholar
  5. R. L. Sacco, “Newer risk factors for stroke,” Neurology, vol. 57, no. 5, supplement 2, pp. S31–S34, 2001. View at Google Scholar · View at Scopus
  6. R. X. You, J. J. McNeil, H. M. O'Malley, S. M. Davis, A. G. Thrift, and G. A. Donnan, “Risk factors for stroke due to cerebral infarction in young adults,” Stroke, vol. 28, no. 10, pp. 1913–1918, 1997. View at Google Scholar · View at Scopus
  7. A. J. Grau, C. Weimar, F. Buggle et al., “Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank,” Stroke, vol. 32, no. 11, pp. 2559–2566, 2001. View at Google Scholar · View at Scopus
  8. R. L. Sacco, R. Adams, G. Albers et al., “Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American heart association/American stroke association council on stroke—co-sponsored by the council on cardiovascular radiology and intervention. The American academy of neurology affirms the value of this guideline,” Stroke, vol. 37, no. 2, pp. 577–617, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Vagnerova, I. P. Koerner, and P. D. Hurn, “Gender and the injured brain,” Anesthesia and Analgesia, vol. 107, no. 1, pp. 201–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Caso, M. Paciaroni, G. Agnelli et al., “Gender differences in patients with acute ischemic stroke,” Women's Health, vol. 6, no. 1, pp. 51–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. C. Beal, “Gender and stroke symptoms: a review of the current literature,” Journal of Neuroscience Nursing, vol. 42, no. 2, pp. 80–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Appelros, B. Stegmayr, and A. Terent, “Sex differences in stroke epidemiology: a systematic review,” Stroke, vol. 40, no. 4, pp. 1082–1090, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Yuan, C. Siegel, Z. Zeng, J. Li, F. Liu, and L. D. McCullough, “Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke,” Experimental Neurology, vol. 217, no. 1, pp. 210–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. D. Hurn, S. J. Vannucci, and H. Hagberg, “Adult or perinatal brain injury: does sex matter?” Stroke, vol. 36, no. 2, pp. 193–195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. P. D. Hurn and L. M. Brass, “Estrogen and stroke: a balanced analysis,” Stroke, vol. 34, no. 2, pp. 338–341, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. P. D. Hurn and I. M. Macrae, “Estrogen as a neuroprotectant in stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 20, no. 4, pp. 631–652, 2000. View at Google Scholar · View at Scopus
  17. T. Hawk, Y. Q. Zhang, G. Rajakumar, A. L. Day, and J. W. Simpkins, “Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats,” Brain Research, vol. 796, no. 1-2, pp. 296–298, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Hill and R. H. Fitch, “Sex differences in mechanisms and outcome of neonatal hypoxia-ischemia in rodent models: implications for sex-specific neuroprotection in clinical neonatal practice,” Neurology Research International, vol. 2012, Article ID 867531, 9 pages, 2012. View at Publisher · View at Google Scholar
  19. M. Liu, M. H. Kelley, P. S. Herson, and P. D. Hurn, “Neuroprotection of sex steroids,” Minerva Endocrinologica, vol. 35, no. 2, pp. 127–143, 2010. View at Google Scholar · View at Scopus
  20. G. E. Hoffman, I. Merchenthaler, and S. L. Zup, “Neuroprotection by ovarian hormones in animal models of neurological disease,” Endocrine, vol. 29, no. 2, pp. 217–231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Suzuki, C. M. Brown, and P. M. Wise, “Mechanisms of neuroprotection by estrogen,” Endocrine, vol. 29, no. 2, pp. 209–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. V. R. Feeser and R. M. Loria, “Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions,” Journal of Neuroimmunology, vol. 237, no. 1-2, pp. 4–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. L. Gibson, B. Coomber, and J. Rathbone, “Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke?” Neuroscientist, vol. 15, no. 4, pp. 324–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. Janowsky, “The role of androgens in cognition and brain aging in men,” Neuroscience, vol. 138, no. 3, pp. 1015–1020, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. T. M. Beer, L. B. Bland, J. R. Bussiere et al., “Testosterone loss and estradiol administration modify memory in men,” Journal of Urology, vol. 175, no. 1, pp. 130–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. H. Yang, E. Perez, J. Cutright et al., “Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model,” Journal of Applied Physiology, vol. 92, no. 1, pp. 195–201, 2002. View at Google Scholar · View at Scopus
  27. J. W. Gatson and M. Singh, “Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes,” Endocrinology, vol. 148, no. 5, pp. 2458–2464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Cheng, N. J. Alkayed, and P. D. Hurn, “Deleterious effects of dihydrotestosterone on cerebral ischemic injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 9, pp. 1553–1562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Pan, H. Zhang, A. B. Acharya, P. H. Patrick, D. Oliver, and J. E. Morley, “Effect of testosterone on functional recovery in a castrate male rat stroke model,” Brain Research, vol. 1043, no. 1-2, pp. 195–204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. H. Yang, R. Liu, Y. Wen et al., “Neuroendocrine mechanism for tolerance to cerebral ischemia-reperfusion injury in male rats,” Journal of Neurobiology, vol. 62, no. 3, pp. 341–351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Meusburger and J. R. Keast, “Testosterone and nerve growth factor have distinct but interacting effects on structure and neurotransmitter expression of adult pelvic ganglion cells in vitro,” Neuroscience, vol. 108, no. 2, pp. 331–340, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Ahlbom, “Androgen treatment of neonatal rats decreases susceptibility of cerebellar granule neurons to oxidative stress in vitro,” European Journal of Neuroscience, vol. 11, no. 4, pp. 1285–1291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Ahlbom, G. S. Prins, and S. Ceccatelli, “Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism,” Brain Research, vol. 892, no. 2, pp. 255–262, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Hammond, Q. Le, C. Goodyer, M. Gelfand, M. Trifiro, and A. LeBlanc, “Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons,” Journal of Neurochemistry, vol. 77, no. 5, pp. 1319–1326, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. C. J. Pike, “Testosterone attenuates β-amyloid toxicity in cultured hippocampal neurons,” Brain Research, vol. 919, no. 1, pp. 160–165, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Chisu, P. Manca, G. Lepore, S. Gadau, M. Zedda, and V. Farina, “Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into α-tubulin in a mouse neuroblastoma cell line,” Archives Italiennes de Biologie, vol. 144, no. 2, pp. 63–73, 2006. View at Google Scholar · View at Scopus
  37. A. Caruso, V. Di Giorgi Gerevini, M. Castiglione et al., “Testosterone amplifies excitotoxic damage of cultured oligodendrocytes,” Journal of Neurochemistry, vol. 88, no. 5, pp. 1179–1185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. C. J. Pike, T. V. V. Nguyen, M. Ramsden, M. Yao, M. P. Murphy, and E. R. Rosario, “Androgen cell signaling pathways involved in neuroprotective actions,” Hormones and Behavior, vol. 53, no. 5, pp. 693–705, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. T. Lang and L. D. McCullough, “Pathways to ischemic neuronal cell death: are sex differences relevant?” Journal of Translational Medicine, vol. 6, article 33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Vakili, F. Hosseinzadeh, and T. Sadogh, “Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia,” Brain Research, vol. 1170, pp. 97–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Sun, L. Chen, X. Wei, Y. Xiang, X. Liu, and X. Zhang, “The Akt/GSK-3β pathway mediates flurbiprofen-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rats,” Biochemical and Biophysical Research Communications, vol. 409, no. 4, pp. 808–813, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Ji, J. Miao, X. Zhang et al., “Inhibition of sonic hedgehog signaling aggravates brain damage associated with the down-regulation of Gli1, Ptch1 and SOD1 expression in acute ischemic stroke,” Neuroscience Letters, vol. 506, no. 1, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  43. R. Noor, C. X. Wang, and A. Shuaib, “Hyperthermia masks the neuroprotective effects of tissue plaminogen activator,” Stroke, vol. 36, no. 3, pp. 665–669, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. R. A. Swanson, M. T. Morton, G. Tsao-Wu, R. A. Savalos, C. Davidson, and F. R. Sharp, “A semiautomated method for measuring brain infarct volume,” Journal of Cerebral Blood Flow and Metabolism, vol. 10, no. 2, pp. 290–293, 1990. View at Google Scholar · View at Scopus
  45. M. Uchida, J. M. Palmateer, P. S. Herson, A. C. DeVries, J. Cheng, and P. D. Hurn, “Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 8, pp. 1454–1462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Zhu, L. Wang, L. Zhang et al., “Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice,” Neuroscience, vol. 169, no. 2, pp. 758–769, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. L. L. Jeppesen, H. S. Jørgensen, H. Nakayama, H. O. Raaschou, T. S. Olsen, and K. Winther, “Decreased serum testosterone in men with acute ischemic stroke,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 6, pp. 749–754, 1996. View at Google Scholar · View at Scopus
  48. T. J. K. Toung, R. J. Traystman, and P. D. Hurn, “Estrogen-mediated neuroprotection after experimental stroke in male rats,” Stroke, vol. 29, no. 8, pp. 1666–1670, 1998. View at Google Scholar · View at Scopus
  49. R. Orlando, A. Caruso, G. Molinaro et al., “Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures,” Brain Research, vol. 1165, no. 1, pp. 21–29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Zhang, N. Champagne, L. K. Beitel, C. G. Goodyer, M. Trifiro, and A. LeBlanc, “Estrogen and androgen protection of human neurons against intracellular amyloid β1-42 toxicity through heat shock protein 70,” Journal of Neuroscience, vol. 24, no. 23, pp. 5315–5321, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. C. A. Berrevoets, A. Umar, and A. O. Brinkmann, “Antiandrogens: selective androgen receptor modulators,” Molecular and Cellular Endocrinology, vol. 198, no. 1-2, pp. 97–103, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Haendler and A. Cleve, “Recent developments in antiandrogens and selective androgen receptor modulators,” Molecular and Cellular Endocrinology, vol. 352, no. 1-2, pp. 79–91, 2012. View at Publisher · View at Google Scholar
  53. T. V. V. Nguyen, M. Yao, and C. J. Pike, “Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection,” Endocrinology, vol. 148, no. 6, pp. 2936–2943, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. C. I. Wong, W. R. Kelce, M. Sar, and E. M. Wilson, “Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide,” The Journal of Biological Chemistry, vol. 270, no. 34, pp. 19998–20003, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. L. M. Garcia-Segura, “Aromatase in the brain: not just for reproduction anymore,” Journal of Neuroendocrinology, vol. 20, no. 6, pp. 705–712, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. H. V. O. Carswell, A. F. Dominiczak, L. M. Garcia-Segura, N. Harada, J. B. Hutchison, and I. M. Macrae, “Brain aromatase expression after experimental stroke: topography and time course,” Journal of Steroid Biochemistry and Molecular Biology, vol. 96, no. 1, pp. 89–91, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Zhou, N. Lehan, U. Wehrenberg et al., “Neuroprotection by estradiol: a role of aromatase against spine synapse loss after blockade of GABAA receptors,” Experimental Neurology, vol. 203, no. 1, pp. 72–81, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Arboix, E. Comes, L. García-Eroles, J. B. Massons, M. Oliveres, and M. Balcells, “Prognostic value of very early seizures for in-hospital mortality in atherothrombotic infarction,” European Neurology, vol. 50, no. 2, pp. 78–84, 2003. View at Publisher · View at Google Scholar · View at Scopus